<SEC-DOCUMENT>0001274737-22-000064.txt : 20220915
<SEC-HEADER>0001274737-22-000064.hdr.sgml : 20220915
<ACCEPTANCE-DATETIME>20220915160335
ACCESSION NUMBER:		0001274737-22-000064
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220915
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220915
DATE AS OF CHANGE:		20220915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXAGEN INC.
		CENTRAL INDEX KEY:			0001274737
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39049
		FILM NUMBER:		221245823

	BUSINESS ADDRESS:	
		STREET 1:		1261 LIBERTY WAY
		CITY:			VISTA
		STATE:			CA
		ZIP:			92081
		BUSINESS PHONE:		(760) 560-1501

	MAIL ADDRESS:	
		STREET 1:		1261 LIBERTY WAY
		CITY:			VISTA
		STATE:			CA
		ZIP:			92081

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXAGEN DIAGNOSTICS INC
		DATE OF NAME CHANGE:	20031230
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>exdx-20220915.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:a944869c-9527-48e0-9937-aeba75b47e0d,g:ad3d43e1-ed49-4e9b-aa6c-71416205d4a9,d:36199c273bc6437fad89ae232f7e3273--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>exdx-20220915</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M180L2ZyYWc6MGIyYjlkYmRlYTVmNDFhYTlkODZlZTVjNTRhMGM1NGIvdGFibGU6MmY2MmQxMzFkMDNiNDYwNzlmYzIwYjNkMmVkMTBmZjAvdGFibGVyYW5nZToyZjYyZDEzMWQwM2I0NjA3OWZjMjBiM2QyZWQxMGZmMF8wLTEtMS0xLTQ2NTQ5_165e160c-4180-4e1e-8bf7-4d4613231a1d">0001274737</ix:nonNumeric><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M180L2ZyYWc6MGIyYjlkYmRlYTVmNDFhYTlkODZlZTVjNTRhMGM1NGIvdGFibGU6MmY2MmQxMzFkMDNiNDYwNzlmYzIwYjNkMmVkMTBmZjAvdGFibGVyYW5nZToyZjYyZDEzMWQwM2I0NjA3OWZjMjBiM2QyZWQxMGZmMF8xLTEtMS0xLTQ2NTQ5_c3022e7c-8ce3-46cf-9134-53adb531dfa0">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="exdx-20220915.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib7fec472c1a446339220282dc241a296_D20210805-20210805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001274737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-05</xbrli:startDate><xbrli:endDate>2021-08-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i36199c273bc6437fad89ae232f7e3273_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTEy_2a5a851f-96e2-4408-bf30-168cd6b8a0e2">8-K</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934 </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yMjk_0fbd25c2-1c3a-4a7f-9fc8-87402f801e1f">September 15, 2022</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTEz_1680aa00-520b-46d7-aca3-e6a324a06c0c">EXAGEN INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:32.886%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.601%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6N2I3N2ExNWQ3MjA5NDVmMmI5YWFiZGNhZjM3MWMyOGIvdGFibGVyYW5nZTo3Yjc3YTE1ZDcyMDk0NWYyYjlhYWJkY2FmMzcxYzI4Yl8xLTAtMS0xLTQ2NTQ5_93a6e947-cc7c-41cf-937e-11e818eb4622">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6N2I3N2ExNWQ3MjA5NDVmMmI5YWFiZGNhZjM3MWMyOGIvdGFibGVyYW5nZTo3Yjc3YTE1ZDcyMDk0NWYyYjlhYWJkY2FmMzcxYzI4Yl8xLTItMS0xLTQ2NTQ5_076d1404-8148-4dd3-86ce-ecf5bee5c686">001-39049</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6N2I3N2ExNWQ3MjA5NDVmMmI5YWFiZGNhZjM3MWMyOGIvdGFibGVyYW5nZTo3Yjc3YTE1ZDcyMDk0NWYyYjlhYWJkY2FmMzcxYzI4Yl8xLTQtMS0xLTQ2NTQ5_2c273da1-4c60-4c11-bfdf-0fcaf00a85c3">20-0434866</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE2_6ea5f31d-a496-48ed-ba8e-2814912a8352">1261 Liberty Way</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE3_9369833a-a86f-45ae-b3da-b9537a2878bd">Vista</ix:nonNumeric>, <ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE4_dfb3ddfa-3acb-4661-a05e-f9ea7d989f65">CA</ix:nonNumeric> <ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE0_d29cd655-0c7f-46c6-a207-f0e10163f257">92081</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code) </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE1_1d898c82-8404-4665-8cfe-4d1014a18739">760</ix:nonNumeric>) <ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE5_8b452a05-3349-4fa3-a20c-8b5737ce4ef6">560-1501</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code) </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report) </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"></td><td style="width:2.331%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:95.306%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8wLTAtMS0xLTQ2NTQ5_8f4f5901-5520-41f7-b6f1-937e7ca107e5">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8xLTAtMS0xLTQ2NTQ5_ae7d6762-b7c1-496c-8a81-708cd934a096">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8yLTAtMS0xLTQ2NTQ5_a8c57ae6-584a-4f80-b690-7f54a0b59658">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8zLTAtMS0xLTQ2NTQ5_403c9bad-dc7a-442f-8200-a5035e57f0ec">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.679%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.959%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.682%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6YTFhNjQ4MGVjNWMxNDUyM2JmMDJjYWQxMjZjN2ZlMjMvdGFibGVyYW5nZTphMWE2NDgwZWM1YzE0NTIzYmYwMmNhZDEyNmM3ZmUyM18yLTAtMS0xLTQ2NTQ5_342b9b9d-0874-46b5-903e-c57594f5aed8">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6YTFhNjQ4MGVjNWMxNDUyM2JmMDJjYWQxMjZjN2ZlMjMvdGFibGVyYW5nZTphMWE2NDgwZWM1YzE0NTIzYmYwMmNhZDEyNmM3ZmUyM18yLTItMS0xLTQ2NTQ5_a6c3399e-543c-4681-bef2-05b4c37a9274">XGN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6YTFhNjQ4MGVjNWMxNDUyM2JmMDJjYWQxMjZjN2ZlMjMvdGFibGVyYW5nZTphMWE2NDgwZWM1YzE0NTIzYmYwMmNhZDEyNmM3ZmUyM18yLTQtMS0xLTQ2NTQ5_0422782b-2a7c-4861-a775-b1b5bf4c1fee">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTIw_6dd47273-301a-4f84-b07b-189c80d396c0">&#9746;</ix:nonNumeric> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTIx_5ae1867a-f1c8-4b4f-ad33-d505c3b40496">&#9744;</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01 Entry into a Material Definitive Agreement. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 15, 2022, Exagen Inc., or the Company, entered into a Sales Agreement, or the Sales Agreement, with Cowen and Company, LLC, or Cowen, with respect to an at the market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.001 per share, or Common Stock, having an aggregate offering price of up to $50.0 million, or the Placement Shares, through Cowen as its sales agent.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Sales Agreement, the Company will set the parameters for the sale of the Placement Shares, including the number of Placement Shares to be issued, the time period during which sales are requested to be made, limitations on the number of Placement Shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms of the Sales Agreement, Cowen may sell the Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act of 1933, as amended, including, without limitation, sales made through the Nasdaq Global Market or on any other trading market for the Common Stock. Cowen will use commercially reasonable efforts to sell the Placement Shares from time to time, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay Cowen a commission equal to three percent (3.0%) of the gross sales proceeds of any Placement Shares sold through Cowen under the Sales Agreement, and also has provided Cowen with customary indemnification and contribution rights.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is not obligated to make any sales of Common Stock under the Sales Agreement. The offering of Placement Shares pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of all Placement Shares subject to the Sales Agreement or (ii) termination of the Sales Agreement in accordance with its terms.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any Placement Shares to be offered and sold under the Sales Agreement will be issued and sold pursuant to the Company&#8217;s Registration Statement on Form S&#8209;3 (File No. 333&#8209;250015), which became effective on November 19, 2020, or the Registration Statement. The Company plans to file a prospectus supplement with the Securities and Exchange Commission on September 15, 2022 in connection with the offer and sale of the Placement Shares pursuant to the Sales Agreement.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description of the Sales Agreement is not complete and is qualified in its entirety by reference to the full text of the form of the Sales Agreement filed as Exhibit 1.1 hereto, which is incorporated herein by reference. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Current Report on Form 8&#8209;K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The opinion of the Company&#8217;s counsel regarding the validity of the Placement Shares is filed as Exhibit 5.1 hereto. This opinion is also filed with reference to, and is hereby incorporated by reference into, the Registration Statement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">            </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Financial Statements and Exhibits. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex11-xgnxsalesagreement.htm">Sales Agreement, dated as of September 15, 2022, by and between Exagen Inc. and Cowen and Company, LLC</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex51-exagenxatmxformof51op.htm">Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex51-exagenxatmxformof51op.htm">Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in Exhibit 5.1).</a></span></div></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* Attachments omitted pursuant to Item 601(a)(5) of Regulation S-K. The names of the omitted attachments are referenced in the as-filed Exhibit.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tr><td style="width:1.0%"></td><td style="width:42.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.735%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXAGEN INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: September 15, 2022</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kamal Adawi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Kamal Adawi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex11-xgnxsalesagreement.htm
<DESCRIPTION>EX-1.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i26424b9a90484f998a65145809733d5a_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 1.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXAGEN INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">$50,000,000 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SALES AGREEMENT<br></font></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">September 15, 2022</font></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cowen and Company, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">599 Lexington Avenue</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">New York, NY 10022</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exagen Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), confirms its agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) with Cowen and Company, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Cowen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Issuance and Sale of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through Cowen, acting as agent and&#47;or principal, shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), having an aggregate offering price of up to $50,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Maximum Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> on the number of shares of Common Stock issued and sold under this Agreement shall be the sole responsibility of the Company, and Cowen shall have no obligation in connection with such compliance.  The issuance and sale of Common Stock through Cowen will be effected pursuant to the Registration Statement (as defined below) filed by the Company and declared effective by the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement (as defined below) to issue the Common Stock.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), with the Commission a registration statement on Form S-3 (File No. 333-250015), including a base prospectus, relating to certain securities, including the Common Stock, to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Company has prepared a prospectus supplement specifically relating to the Placement Shares (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Prospectus Supplement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the base prospectus included as part of such registration statement.  The Company has furnished to Cowen, for use by Cowen, copies of the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Placement Shares.  Except where the context otherwise requires, such registration statement, and any post-effective amendment thereto, as amended when it became effective, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B or 462(b) of the Securities Act, or any subsequent registration statement on Form S-3 filed pursuant to Rule 415(a)(6) under the Securities Act by the Company with respect to the Placement Shares, is herein called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Registration&#160;Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;  The base prospectus, including all documents incorporated therein by reference, included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such prospectus and&#47;or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, together with any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433 under the Securities Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Rule 433</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), relating to the Placement Shares that (i) is consented to by Cowen, hereinafter referred to as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Permitted Free Writing Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; (ii) is required to be filed with the Commission by the Company or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i), in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g), is herein called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#8221; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Incorporated Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include any copy filed with the Commission pursuant to the Electronic Data Gathering Analysis and Retrieval System (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EDGAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Placements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each time that the Company wishes to issue and sell the Placement Shares hereunder (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Placement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), it will notify Cowen by email notice (or other method mutually agreed to in writing by the parties) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Placement Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) containing the parameters in accordance with which it desires the Placement Shares to be sold, which shall at a minimum include the number of shares of Placement Shares to be issued, the time period during which sales are requested to be made, any limitation on the number of Placement Shares that may be sold in any one Trading Day (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and any minimum price below which sales may not be made, a form of which containing such minimum sales parameters necessary is attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Placement Notice shall originate from any of the individuals from the Company set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from Cowen set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as such </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> may be amended from time to time. The Placement Notice shall be effective upon receipt by Cowen unless and until (i) in accordance with the notice requirements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Cowen declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares have been sold, (iii) in accordance with the notice requirements set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company suspends or terminates the Placement Notice, (iv) the Company issues a subsequent Placement Notice with parameters superseding those on the earlier dated Placement Notice, or (v) this Agreement has been terminated under the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.   The amount of any discount, commission or other compensation to be paid by the Company to Cowen in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  It is expressly acknowledged and agreed that neither the Company nor Cowen will have any </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to Cowen and Cowen does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein.  In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Sale of Placement Shares by Cowen.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Subject to the terms and conditions herein set forth, upon the Company&#8217;s delivery of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, Cowen, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Stock Market, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Nasdaq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to sell such Placement Shares up to the amount specified, and otherwise in accordance with the terms of such Placement Notice.  Cowen will provide written confirmation to the Company (including by email correspondence to each of the individuals of the Company set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the volume-weighted average price of the Placement Shares sold, and the Net Proceeds (as defined below) payable to the Company.  In the event the Company engages Cowen for a sale of Placement Shares that would constitute a &#8220;block&#8221; within the meaning of Rule 10b-18(a)(5) under the Exchange Act (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Block Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Company will provide Cowen, at Cowen&#8217;s request and upon reasonable advance notice to the Company, on or prior to the Settlement Date (as defined below), the opinions of counsel, accountant&#8217;s letter and officers&#8217; certificates set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof, each dated the Settlement Date, and such other documents and information as Cowen shall reasonably request. Cowen may sell Placement Shares by any method permitted by law deemed to be an &#8220;at the market&#8221; offering as defined in Rule 415 of the Securities Act, including without limitation sales made through Nasdaq or on any other existing trading market for the Common Stock.  Cowen shall not purchase Placement Shares for its own account as principal unless expressly authorized to do so by the Company in a Placement Notice.  The Company acknowledges and agrees that (i) there can be no assurance that Cowen will be successful in selling Placement Shares, and (ii) Cowen will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by Cowen to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares as required under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For the purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any day on which the Company&#8217;s Common Stock is purchased and sold on the principal market on which the Common Stock is listed or quoted.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Agreement, the Company shall not offer, sell or deliver, or request the offer or sale, of any Placement Shares pursuant to this Agreement and, by notice to Cowen given by telephone (confirmed promptly by email), shall cancel any instructions for the offer or sale of any Placement Shares, and Cowen shall not be obligated to offer or sell any Placement Shares, (i) during any period in which the Company is in possession of material non-public information, or (ii) at any time from and including the date on which the Company shall issue a press release containing, or shall otherwise publicly announce, its earnings, revenues </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or other results of operations (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Earnings Announcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) through and including the time that the Company files a Quarterly Report on Form 10-Q or an Annual Report on Form 10-K that includes consolidated financial statements as of and for the same period or periods, as the case may be, covered by such Earnings Announcement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Suspension of Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company or Cowen may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), suspend any sale of Placement Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such suspension shall not affect or impair either party&#8217;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice.  While a suspension is in effect, any obligations under&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#160;7(p) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;with respect to delivery of certificates, opinions or comfort letters to Cowen, shall be waived&#59;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such certificates, opinions or comfort letters shall be delivered to Cowen prior to the resumption of sales of any Placement&#160;Shares.&#160; Each of the parties agrees that no such notice under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be effective against the other unless it is made to one of the individuals named on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereto, as such schedule may be amended from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Registration Statement was declared effective on November 19, 2020.  Notwithstanding any other provision of this Agreement, during any period in which the Registration Statement is no longer effective under the Securities Act, the Company shall promptly notify Cowen, the Company shall not request the sale of any Placement Shares, and Cowen shall not be obligated to sell or offer to sell any Placement Shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Settlement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Settlement of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the second (2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Settlement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and the first such Settlement Date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">First Delivery Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Net Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) will be equal to the aggregate sales price received by Cowen at which such Placement Shares were sold, after deduction for (i)&#160;Cowen&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof, (ii) any other amounts due and payable by the Company to Cowen hereunder pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Expenses) hereof, and (iii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Delivery of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting Cowen&#8217;s or its designee&#8217;s account (provided Cowen shall have given the Company written notice of such designee prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may be mutually agreed upon by the parties hereto which in all cases shall be freely tradeable, transferable, registered shares in good deliverable form.  On each Settlement Date, Cowen will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date.  The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver duly authorized Placement Shares on a Settlement Date, the Company agrees that in addition to and in no way limiting the rights and obligations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Indemnification and Contribution) hereto, it will (i)&#160;hold Cowen harmless against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company and (ii) pay to Cowen (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Representations and Warranties of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as disclosed in the Registration Statement, the Prospectus or the Prospectus Supplement, including the Incorporated Documents, the Company represents and warrants to, and agrees with, Cowen that as of (i) the date of this Agreement, (ii) each Time of Sale (as defined below), (iii) each Settlement Date, and (iv) each Bring-Down Date (as defined below) (each date included in (i) through (iv), a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Representation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Registration Statement and Prospectuses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company meets the requirements for use of Form S-3 under the Securities Act. Each of the Registration Statement and any amendment thereto has become effective under the Securities Act. No stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued by the Commission under the Securities Act, no order preventing or suspending the use of the Prospectus has been issued and no proceedings for any of those purposes have been instituted by the Commission or are pending or, to the Company&#8217;s knowledge, contemplated by the Commission. The Company has complied with each request (if any) from the Commission for additional information. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material respects with the requirements of the Securities Act and the rules and regulations of the Commission under the Securities Act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Prospectus and any amendment or supplement thereto, at the time each was filed with the Commission, complied in all material respects with the requirements of the Securities Act and the Securities Act Regulations. The Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, when they became effective or at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the Exchange Act and the rules and regulations of the Commission under the Exchange Act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Act Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Accurate Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Neither the Registration Statement nor any amendment thereto, at its effective time, and as of each Representation Date, contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time of any filing with the Commission pursuant to Rule 424(b), at each Representation Date, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Time of Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means with respect to each offering of Placement Shares pursuant to this Agreement, the time of Cowen&#8217;s initial entry into contracts with purchasers for the sale of such Placement Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement (or any amendment thereto) or the Prospectus (or any amendment or supplement thereto, including any prospectus wrapper) made in reliance upon and in conformity with written information furnished to the Company by Cowen expressly for use therein. For purposes of this Agreement, the only information so furnished shall be made in reliance upon and in conformity with information relating to Agent&#8217;s Information (as defined below).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Permitted Free Writing Prospectuses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No Permitted Free Writing Prospectus conflicts or will conflict with the information contained in the Registration Statement or the Prospectus and any preliminary or other prospectus deemed to be a part thereof that has not been superseded or modified.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Company Not Ineligible Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest time thereafter that the Company or another offering participant made a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> offer&#8221; (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Placement Shares and at the date hereof, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Distribution of Offering Material By the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company has not distributed and will not distribute, prior to the completion of Cowen&#8217;s distribution of the Placement Shares, any offering material in connection with the offering and sale of the Placement Shares other than the Prospectus or the Registration Statement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Emerging Growth Company Status.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> From the time of the initial filing of the Registration Statement with the Commission, the Company has been and is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Emerging Growth Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Company agrees to notify Cowen promptly upon the Company ceasing to be an Emerging Growth Company.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Independent Accountants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The accountants who certified the financial statements and supporting schedules included or incorporated by reference in the Registration Statement and the Prospectus are an independent registered public accounting firm as required by the Securities Act, the Securities Act Regulations and the Public Company Accounting Oversight Board.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The financial statements included or incorporated by reference in the Registration Statement and the Prospectus, together with the related schedules and notes, present fairly, in all material respects, the financial position of the Company at the dates indicated and the statement of operations, stockholders&#8217; equity and cash flows of the Company for the periods specified&#59; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) applied on a consistent basis throughout the periods involved, except in the case of unaudited interim financial statements, subject to year-end audit adjustments and the exclusion of certain footnotes as permitted by the applicable rules of the Commission. The supporting schedules included in the Registration Statement, if any, present fairly, in all material respects, in accordance with GAAP the information required to be stated therein. The selected financial data and the summary financial information included in the Registration Statement and the Prospectus present fairly, in all material respects, the information shown therein and have been compiled on a basis consistent with that of the audited financial statements included therein. Except as included therein, no historical or pro forma financial statements or supporting schedules are required to be included or incorporated by reference in the Registration Statement or the Prospectus under the Securities Act or the Securities Act Regulations. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt;text-decoration:underline">XBRL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The interactive data in eXtensible Business Reporting Language included or incorporated by reference in each Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt;text-decoration:underline">No Material Adverse Change in Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise stated therein, since the respective dates as of which information is given in the Registration Statement or the Prospectus, (A) there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company, whether or not arising in the ordinary course of business (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (B) there have been no transactions entered into by the Company, other than those in the ordinary course of business, which are material with respect to the Company, and (C) there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Good Standing of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company has been duly organized and is validly existing as a corporation in good standing under the laws of the State of Delaware and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus and to enter into and perform its obligations under this Agreement&#59; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not result in a Material Adverse Change.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt;text-decoration:underline">No Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company has no subsidiaries.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt;text-decoration:underline">Capitalization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The authorized, issued and outstanding shares of capital stock of the Company are as set forth in the Registration Statement and the Prospectus under the heading &#8220;Description of Capital Stock&#8221; (except for subsequent issuances, if any, pursuant to this </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Agreement, pursuant to reservations, agreements or employee benefit plans referred to in the Registration Statement and the Prospectus or pursuant to the exercise of convertible securities or options referred to in the Registration Statement and the Prospectus). The outstanding shares of capital stock of the Company have been duly authorized and validly issued and are fully paid and nonassessable. None of the outstanding shares of capital stock of the Company were issued in violation of the preemptive or other similar rights of any securityholder of the Company.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Authorization of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement has been duly authorized, executed and delivered by the Company.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Authorization and Description of Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Placement Shares have been duly authorized for issuance and sale pursuant to this Agreement and, when issued and delivered by the Company pursuant to this Agreement against payment of the consideration set forth herein, will be validly issued and fully paid and nonassessable&#59; and the issuance of the Placement Shares is not subject to the preemptive or other similar rights of any securityholder of the Company. The Common Stock conforms to all statements relating thereto contained in the Registration Statement and the Prospectus and such description conforms in all material respects to the rights set forth in the instruments defining the same. No holder of Placement Shares will be subject to personal liability by reason of being such a holder.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Registration Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. There are no persons with registration rights or other similar rights to have any securities registered for sale pursuant to the Registration Statement or otherwise registered for sale or sold by the Company under the Securities Act pursuant to this Agreement, other than those rights that have been disclosed in the Registration Statement and the Prospectus and have been waived.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Absence of Violations, Defaults and Conflicts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company is not (A) in violation of its charter, by-laws or similar organizational document, (B) in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company is a party or by which it may be bound or to which any of the properties or assets of the Company is subject (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreements and Instruments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), except for such defaults that would not, singly or in the aggregate, result in a Material Adverse Change, or (C) in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Company or any of its respective properties, assets or operations (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), except for such violations that would not, singly or in the aggregate, result in a Material Adverse Change. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and in the Registration Statement and the Prospectus (including the issuance and sale of the Placement Shares and the use of the proceeds from the sale of the Placement Shares as described therein under the caption &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and compliance by the Company with its obligations hereunder have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company pursuant to, the Agreements and Instruments (except for </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such conflicts, breaches, defaults or Repayment Events or liens, charges or encumbrances that would not, singly or in the aggregate, result in a Material Adverse Change), nor will such action result in any violation of the provisions of the charter, by-laws or similar organizational document of the Company or any material violation of any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity. As used herein, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Repayment Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#8217;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">No Reliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company has not relied upon Cowen or legal counsel for Cowen for any legal, tax or accounting advice in connection with the offering and sale of the Placement Shares.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt;text-decoration:underline">Absence of Labor Dispute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No labor dispute with the employees of the Company exists or, to the knowledge of the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers, customers or contractors, which, in either case, would result in a Material Adverse Change.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt;text-decoration:underline">Absence of Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as disclosed in the Registration Statement and the Prospectus, there is no action, suit, proceeding, inquiry or investigation before or brought by any Governmental Entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company, which would reasonably be expected to result in a Material Adverse Change, or which would reasonably be expected to materially and adversely affect its properties or assets or the consummation of the transactions contemplated in this Agreement or the performance by the Company of its obligations hereunder&#59; and the aggregate of all pending legal or governmental proceedings to which the Company is a party or of which any of its respective properties or assets is the subject which are not described in the Registration Statement  and the Prospectus, including ordinary routine litigation incidental to the business, would not reasonably be expected to result in a Material Adverse Change.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Accuracy of Exhibits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. There are no contracts or documents which are required to be described in the Registration Statement or the Prospectus or filed as exhibits to the Registration Statement which have not been so described and filed as required.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Absence of Further Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Governmental Entity is necessary or required for the performance by the Company of its obligations hereunder, in connection with the offering, issuance or sale of the Placement Shares hereunder or the consummation of the transactions contemplated by this Agreement, except such as have been already obtained or as may be required under the Securities Act, the Securities Act Regulations, the rules of the Nasdaq Stock Market LLC, state securities laws or the rules of the Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt;text-decoration:underline">Possession of Licenses and Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company possesses such permits, licenses, approvals, consents and other authorizations (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governmental Licenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) issued by the appropriate Governmental Entities necessary to conduct the business as now </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">operated by it (including without limitation, all such certificates, authorizations, registrations, permits, licenses, approvals and consents required by the United States Food and Drug Administration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or any other federal, state, local or foreign agencies or bodies engaged in the regulation of clinical laboratories, clinical trials, diagnostic products or other medical devices), except where the failure so to possess would not, singly or in the aggregate, result in a Material Adverse Change. The Company is in compliance with the terms and conditions of all Governmental Licenses, except where the failure so to comply would not, singly or in the aggregate, result in a Material Adverse Change. All of the Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not, singly or in the aggregate, result in a Material Adverse Change. The Company has not received any written notice of proceedings relating to the revocation or modification of any Governmental Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Change. All applications, notifications, submissions, information, claims, reports and statistics, and other data and conclusions derived therefrom, utilized as the basis for any and all requests for a Governmental License from the FDA or other Governmental Entity relating to the Company, its business and the products and services of the Company, when submitted to the FDA or other Governmental Entity, were true, complete and correct in all material respects as of the date of submission and any necessary or required updates, changes, corrections or modification to such applications, submissions, information and data have been submitted to the FDA or other Governmental Entity. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Title to Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company has good and marketable title to all real property owned by it and good title to all other properties owned by it, in each case, free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind except such as (A) are described in the Registration Statement and the Prospectus or (B) do not, singly or in the aggregate, materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company&#59; and all of the leases and subleases material to the business of the Company, considered as one enterprise, and under which the Company holds properties described in the Registration Statement or the Prospectus, are in full force and effect, and the Company has no written notice of any material claim of any sort that has been asserted by anyone adverse to the rights of the Company under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company to the continued possession of the leased or subleased premises under any such lease or sublease.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;(i) The Company owns or has valid, binding and enforceable licenses or other rights under the patents, patent applications, copyrights, know-how (including trade secrets and other unpatented and&#47;or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names or other intellectual property necessary for, or used in the conduct of the business of the Company and (ii) has, or to the knowledge of the Company, can acquire or license on reasonable terms such intellectual property that is necessary for the proposed conduct of, the business of the Company, in each case, as described in the Registration Statement and the Prospectus (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; to the knowledge of the Company, the registered patents, trademarks, and copyrights, if any, included within the Intellectual Property and which are purported to be owned or exclusively licensed by the Company are valid, enforceable, and subsisting&#59; other than as </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">disclosed in the Registration Statement and the Prospectus, (A) the Company is not obligated to pay a material royalty, grant a license to any material portion of the Intellectual Property, or provide other material consideration to any third party in connection with the Intellectual Property, (B) the Company has not received any written notice of any claim of infringement, misappropriation or conflict with any asserted rights of others with respect to any of the Company&#8217;s products, processes or Intellectual Property, (C) to the knowledge of the Company, neither the sale nor use of any of the discoveries, inventions, products or processes of the Company referred to in the Registration Statement or the Prospectus do or will, to the knowledge of the Company, infringe, misappropriate or violate any right or valid patent claim of any third party, and (D) to the knowledge of the Company, no third party has any ownership right in or to any Intellectual Property that is owned by the Company, other than any co-owner of any patent constituting Intellectual Property who is listed on the records of the U.S. Patent and Trademark Office (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">USPTO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and any co-owner of any patent application constituting Intellectual Property who is named in such patent application, and, to the knowledge of the Company, no third party has any ownership right in or to any Intellectual Property in any field of use that is exclusively licensed to the Company, other than any licensor to the Company of such Intellectual Property.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt;text-decoration:underline">Patents and Patent Applications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All patents and patent applications owned by or exclusively licensed to the Company have, to the knowledge of the Company, been duly and properly filed and maintained&#59; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the USPTO in connection with such applications&#59; and the Company is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which would (A) preclude the grant of a patent in connection with any such application or (B) reasonably be expected to form the basis of a finding of invalidity with respect to any patents that have issued with respect to such applications. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as described in the Registration Statement and the Prospectus or would not, singly or in the aggregate, result in a Material Adverse Change, (A) the Company is not in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (B) the Company has all permits, authorizations and approvals required under any applicable Environmental Laws and is in compliance with their requirements, (C) there are no pending or, to the knowledge of the Company threatened, administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company and (D) there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation, or </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">an action, suit or proceeding by any private party or Governmental Entity, against or affecting the Company relating to Hazardous Materials or any Environmental Laws.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting Controls and Disclosure Controls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company maintains effective internal control over financial reporting (as defined under Rule 13a15 and 15d15 under the Exchange Act Regulations) and a system of internal accounting controls sufficient to provide reasonable assurances that (A) transactions are executed in accordance with management&#8217;s general or specific authorization&#59; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets&#59; (C) access to assets is permitted only in accordance with management&#8217;s general or specific authorization&#59; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the Registration Statement and the Prospectus, since the end of the Company&#8217;s most recent audited fiscal year, there has been (1) no material weakness in the Company&#8217;s internal control over financial reporting (whether or not remediated) and (2) no change in the Company&#8217;s internal control over financial reporting that has materially adversely affected, or is reasonably likely to materially adversely affect, the Company&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Compliance with Health Care Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as described in the Registration Statement and the Prospectus or as would not, singly or in the aggregate, reasonably be expected to give rise to a material liability of the Company, the Company is, and since January 1, 2010 has been, in compliance with, all health care laws applicable to the Company or any of its products or activities, including, but not limited to, the federal Anti-Kickback Statute (42 U.S.C. &#167; 1320a-7b(b)), the Anti-Inducement Law (42 U.S.C. &#167; 1320a-7a(a)(5)), the civil False Claims Act (31 U.S.C. &#167;&#167; 3729 et seq.), the criminal False Claims Law (42 U.S.C. &#167; 1320a-7b(a)), the Stark law (42 U.S.C. &#167; 1395nn), the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &#167;&#167; 1320d et seq.) as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. &#167;&#167; 17921 et seq.), the exclusion laws (42 U.S.C. &#167; 1320a-7), the Federal Food Drug and Cosmetic Act (21 U.S.C. &#167;&#167; 301 et seq.), Medicare (Title XVIII of the Social Security Act), Medicaid (Title XIX of the Social Security Act), the Clinical Laboratory Improvement Amendments (42 U.S.C. &#167; 263a et seq.), the regulations promulgated pursuant to such laws, and any other similar state or federal law (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Health Care Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Company has not received any written notification, correspondence or other communication, including notification of any pending or threatened claim, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any governmental authority, including, without limitation, the FDA, the Federal Trade Commission, the Centers for Medicare &#38; Medicaid Services, or the U.S. Department of Health and Human Services Office of Inspector General, of potential or actual non-compliance by, or liability of, the Company under any Health Care Laws, except, with respect to any of the foregoing, such as would not, in the aggregate, reasonably be expected to have a Material Adverse Change. To the Company&#8217;s knowledge, there are no facts or circumstances that would reasonably be expected to give rise to material liability of the Company under any Health Care Laws. The Company has not had any product or clinical laboratory (whether Company owned or that of a third party manufacturer) subject to a governmental authority (including FDA) shutdown or import or export prohibition, nor received any FDA Form 483 or other governmental authority notice of inspectional observations, &#8220;warning letters,&#8221; &#8220;untitled letters,&#8221; requests to make changes to the Company products, processes or operations, or similar written notice from the FDA or other governmental authority </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">alleging or asserting material noncompliance with any applicable Health Care Laws. To the Company&#8217;s knowledge, neither the FDA nor any other governmental authority is considering such action. The Company is not a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority. Additionally, neither the Company nor any of its employees, officers, directors, or agents has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Safety Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. (a) There have been no recalls, field notifications, field corrections, market withdrawals or replacements, warnings, &#8220;dear doctor&#8221; letters, investigator notices, safety alerts or other notice of action relating to an alleged lack of safety, efficacy, or regulatory compliance of the Company&#8217;s products (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Safety Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (b) to the Company&#8217;s knowledge, there are no facts that would be reasonably likely to result in (x) a Safety Notice with respect to the Company&#8217;s products or services, or (y) a termination or suspension of marketing or testing of any of the Company&#8217;s products or services. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All United States federal income tax returns of the Company required by law to be filed have been filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided. The Company has filed all other tax returns that are required to have been filed by it pursuant to applicable foreign, state, local or other law except insofar as the failure to file such returns would not result in a Material Adverse Change, and has paid all material taxes due pursuant to such returns or pursuant to any assessment received by the Company, except for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by the Company. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined are adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any inadequacy that would not result in a Material Adverse Change. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ff)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company carries or is entitled to the benefits of insurance, with financially sound and reputable insurers, in such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or similar business, and all such insurance is in full force and effect. The Company has no reason to believe that it will not be able (A) to renew its existing insurance coverage as and when such policies expire or (B) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Change. The Company has not been denied any insurance coverage which it has sought or for which it has applied. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(gg)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company is not required, and upon the issuance and sale of the Placement Shares as herein contemplated and the application of the net proceeds therefrom as described in the Registration Statement and the Prospectus will not be required, to </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">register as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(hh)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Absence of Manipulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Neither the Company nor, to the Company&#8217;s knowledge, any affiliate of the Company has taken, nor will the Company or at the direction of the Company any affiliate take, directly or indirectly, any action which is designed, or would be reasonably expected, to cause or result in, or which constitutes, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares or to result in a violation of Regulation M under the Exchange Act.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Corrupt Practices Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. None of the Company or to the knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FCPA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(jj)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Money Laundering Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The operations of the Company are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Money Laundering Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and no action, suit or proceeding by or before any Governmental Entity involving the Company with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(kk)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. None of the Company or to the knowledge of the Company, any director, officer, agent, employee, affiliate or representative of the Company is an individual or entity (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) currently the subject or target of any sanctions administered or enforced by the United States Government, including, without limitation, the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, the United Nations Security Council, the European Union, Her Majesty&#8217;s Treasury, or other relevant sanctions authority (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), nor is the Company located, organized or resident in a country or territory that is the subject of Sanctions&#59; and the Company will not directly or indirectly use the proceeds of the sale of the Placement Shares, or lend, contribute or otherwise make available such proceeds to joint venture partners or other Person, to fund any activities of or business with any Person, or in any country or territory, that, at the time of such funding, is the subject of Sanctions or in any other manner that will result in a violation by any Person (including any Person participating in the transaction, whether as agent, advisor, investor or otherwise) of Sanctions.</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ll)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Lending Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as disclosed in the Registration Statement and the Prospectus, the Company (i) does not have any material lending or other relationship with any banking or lending affiliate of Cowen and (ii) does not intend to use any of the proceeds from the sale of the Placement Shares to repay any outstanding debt owed to any affiliate of Cowen.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(mm)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Statistical and Market-Related Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any statistical and market-related data included in the Registration Statement or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate and, to the extent required, the Company has obtained the written consent to the use of such data from such sources.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(nn)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Rating of Debt Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company has no debt securities or preferred stock that is rated by any &#8220;nationally recognized statistical rating organization&#8221; (as that term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(oo)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company is subject to and in compliance in all material respects with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act.  The Common Stock is registered pursuant to Section 12(b) or Section 12(g) of the Exchange Act and is listed on the Nasdaq, and the Company has taken no action designed to, or reasonably likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the Exchange, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing.  All of the Placement Shares that have been or may be sold under this Agreement have been approved for listing on the Nasdaq, subject to official notice of issuance&#59; the Company has taken all necessary actions to ensure that, upon and at all times after the Nasdaq shall have approved the Placement Shares for listing, it will be in compliance with all applicable corporate governance requirements set forth in the Nasdaq&#8217;s listing rules that are then in effect.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(pp)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Broker Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as disclosed in the Registration Statement and the Prospectus, there are no contracts, agreements or understandings between the Company and any person that would give rise to a valid claim against the Company or Cowen for a brokerage commission, finder&#8217;s fee or other like payment in connection with the offering of the Shares contemplated hereby.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(qq)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. There is and has been no failure on the part of the Company or, to the knowledge of the Company, any of the Company&#8217;s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) applicable to the Company or such directors or officers as of the date hereof, including Section 402 of the Sarbanes-Oxley Act related to loans. The Company has taken all necessary actions to ensure that, upon the effectiveness of the Registration Statement, it will be in compliance with all provisions of the Sarbanes-Oxley Act which the Company is required to comply with as of the effectiveness of the Registration Statement, and is actively taking steps to ensure that it will be in compliance with other provisions of the Sarbanes-Oxley Act that will become applicable to the Company at all times after the effectiveness of the Registration Statement. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(rr)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cybersecurity and Information Technology</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company&#8217;s information technology assets and equipment, computers, technology systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;IT Systems&#8221;) are commercially reasonably adequate for, and operate and perform in all material respects, as required in connection with the operation of the business of the Company as currently conducted, and, to the knowledge of the Company, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company has implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect its confidential information and the integrity, continuous operation, redundancy and security of all material IT Systems and data (including all personal data and sensitive, confidential or regulated data (collectively, the &#8220;Confidential Data&#8221;)) used in connection with the operation of the Company, and has established commercially reasonable disaster recovery plans, procedures and facilities for the business. To the knowledge of the Company, there have been no material breaches, violations, outages or unauthorized uses of or access to the Confidential Data, except for those that have been remedied without material cost or liability. The Company is presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Confidential Data and to the protection of such IT Systems and Confidential Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate have a Material Adverse Change.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ss)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FinCEN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the Company&#8217;s knowledge, all of the beneficial ownership information provided to Cowen or to counsel for Cowen by the Company or its counsel in certification of the beneficial ownership of holders of 25% or more of the Company&#8217;s securities in connection with the offering of the Placement Shares is true, complete and correct.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any certificate signed by an officer of the Company and delivered to Cowen or to counsel for Cowen pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company to Cowen as to the matters set forth therein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company acknowledges that Cowen and, for purposes of the opinions to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof, counsel to the Company and counsel to Cowen, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Covenants of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company covenants and agrees with Cowen that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Registration Statement Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  After the date of this Agreement and during any period in which a Prospectus relating to any Placement Shares is required to be delivered by Cowen under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule&#160;172 under the Securities Act), (i)&#160;the Company will notify Cowen promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference, has been filed with the Commission and&#47;or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus or for additional information (insofar as it relates to the Placement Shares or the transactions </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">contemplated hereby), (ii) the Company will prepare and file with the Commission, promptly upon Cowen&#8217;s request, any amendments or supplements to the Registration Statement or Prospectus that, in Cowen&#8217;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement Shares by Cowen (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the failure of Cowen to make such request shall not relieve the Company of any obligation or liability hereunder, or affect Cowen&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the only remedy Cowen shall have with respect to the failure to make such filing (other than Cowen&#8217;s rights under Section&#160;9 hereof) will be to cease making sales under this Agreement until such amendment or supplement is filed)&#59; (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents incorporated by reference, relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof has been submitted to Cowen within a reasonable period of time before the filing and Cowen has not reasonably objected thereto (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the failure of Cowen to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect Cowen&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and,&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the only remedy Cowen shall have with respect to the failure by the Company to provide Cowen with such copy or the filing of such amendment or supplement despite Cowen&#8217;s objection (other than Cowen&#8217;s rights under Section&#160;9 hereof) shall be to cease making sales under this Agreement) and the Company will furnish to Cowen at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR&#59; (iv) the Company will cause each amendment or supplement to the Prospectus, other than documents incorporated by reference, to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act, and (v) prior to the termination of this Agreement, the Company will notify Cowen if at any time the Registration Statement shall no longer be effective as a result of the passage of time pursuant to Rule 415 under the Securities Act or otherwise. Prior to the initial sale of any Placement Shares, the Company shall file a final Prospectus Supplement pursuant to Rule 424(b) relating to the Placement Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Notice of Commission Stop Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will advise Cowen, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose&#59; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Delivery of Prospectus&#59; Subsequent Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During any period in which a Prospectus relating to the Placement Shares is required to be delivered by Cowen under the Securities Act with respect to a pending sale of the Placement Shares, (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act.  If during such period any event occurs as a result of which the </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify Cowen to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Listing of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During any period in which the Prospectus relating to the Placement Shares is required to be delivered by Cowen under the Securities Act with respect to a pending sale of the Placement Shares (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will use its commercially reasonable efforts to cause the Placement Shares to be listed on Nasdaq and to qualify the Placement Shares for sale under the securities laws of such jurisdictions as Cowen reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Placement Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the Company shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities or file a general consent to service of process in any jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Delivery of Registration Statement and Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will furnish to Cowen and its counsel (at the expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during any period in which a Prospectus relating to the Placement Shares is required to be delivered under the Securities Act (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as Cowen may from time to time reasonably request and, at Cowen&#8217;s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the Company shall not be required to furnish any document (other than the Prospectus) to Cowen to the extent such document is available on EDGAR.  </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.03pt;text-decoration:underline">Earnings Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will make generally available to its security holders as soon as practicable, but in any event not later than 15 months after the end of the Company&#8217;s current fiscal quarter, an earnings statement covering a 12-month period that satisfies the provisions of Section 11(a) and Rule 158 of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereunder, will pay the following expenses all incident to the performance of its obligations hereunder, including, but not limited to, expenses relating to (i) the preparation, printing and filing of the Registration Statement and each amendment and supplement thereto, of each Prospectus and of each amendment and supplement thereto, (ii) the preparation, issuance and delivery of the Placement Shares, (iii) the qualification of the Placement Shares under securities laws in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement, including filing fees (provided, however, that any fees or disbursements of counsel for Cowen in connection therewith shall be paid by Cowen except as set forth in (vii) below), (iv) the printing and delivery</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">to Cowen of copies of the Prospectus and any amendments or supplements thereto, and of this Agreement, (v) the fees and expenses incurred in connection with the listing or qualification of the Placement Shares for trading on Nasdaq, (vi) the filing fees and expenses, if any, of the Commission, (vii) the filing fees and associated legal expenses of Cowen&#8217;s outside counsel for filings with the FINRA Corporate Financing Department which shall not exceed $15,000 and, (viii) the reasonable fees and disbursements of Cowen&#8217;s counsel (including any such disbursements pursuant to clause (vii)) in an amount not to exceed $75,000.    </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#8220;Use of Proceeds.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.69pt;text-decoration:underline">Notice of Other Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  During the pendency of any Placement Notice given hereunder, and for 5 trading days following the termination of any Placement Notice given hereunder, the Company shall provide Cowen notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells, grants any option to sell or otherwise disposes of any shares of Common Stock (other than Placement Shares offered pursuant to the provisions of this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire Common Stock&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such notice shall not be required in connection with the (i) issuance, grant or sale of Common Stock, options to purchase shares of Common Stock or Common Stock issuable upon the exercise of options or other equity awards pursuant to any stock option, stock bonus or other stock plan or arrangement described in the Prospectus, (ii) the issuance of securities in connection with an acquisition, merger or sale or purchase of assets, (iii) the issuance or sale of Common Stock pursuant to any dividend reinvestment plan that the Company may adopt from time to time provided the implementation of such is disclosed to Cowen in advance or (iv) any shares of common stock issuable upon the exchange, conversion or redemption of securities or the exercise of warrants, options or other rights in effect or outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.69pt;text-decoration:underline">Change of Circumstances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will, at any time during a fiscal quarter in which the Company intends to tender a Placement Notice or sell Placement Shares, advise Cowen promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document provided to Cowen pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Due Diligence Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will cooperate with any reasonable due diligence review conducted by Cowen or its agents in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during regular business hours and at the Company&#8217;s principal offices, as Cowen may reasonably request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.69pt;text-decoration:underline">Required Filings Relating to Placement of Placement Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company agrees that on such dates as the Securities Act shall require, the Company will (i)&#160;file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (each and every filing under Rule 424(b), a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Filing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market.  The Company shall disclose in its quarterly reports on Form 10-Q and in its annual report on Form 10-K, the number of the Placement Shares sold through Cowen under this </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Agreement, and the gross proceeds and Net Proceeds to the Company from the sale of the Placement Shares and the compensation paid by the Company with respect to sales of the Placement Shares pursuant to this Agreement during the relevant quarter or, in the case of an Annual Report on Form 10-K, during the fiscal year covered by such Annual Report and the fourth quarter of such fiscal year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15.69pt;text-decoration:underline">Bring-Down Dates&#59; Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  On or prior to the First Delivery Date and each time (i) the Company files the Prospectus relating to the Placement Shares or amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares (other than a prospectus supplement filed in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement) by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of document(s) by reference to the Registration Statement or the Prospectus relating to the Placement Shares&#59; (ii) the Company files an annual report on Form 10-K under the Exchange Act&#59; (iii) the Company files its quarterly reports on Form 10-Q under the Exchange Act&#59; or (iv) the Company files a report on Form 8-K containing amended financial information (other than an earnings release) under the Exchange Act (each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Bring-Down Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#59; the Company shall furnish Cowen with a certificate, in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> within three (3) Trading Days of any Bring-Down Date if requested by Cowen.  The requirement to provide a certificate under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be automatically waived for any Bring-Down Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Bring-Down Date) and the next occurring Bring-Down Date.  Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Bring-Down Date when the Company relied on such waiver and did not provide Cowen with a certificate under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, then before the Company delivers the Placement Notice or Cowen sells any Placement Shares, the Company shall provide Cowen with a certificate, in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, dated the date of the Placement Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Legal Opinion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  On or prior to the First Delivery Date and within three (3) Trading Days of each Bring-Down Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for which no waiver is applicable, the Company shall cause to be furnished to Cowen a written opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or other counsel satisfactory to Cowen, in form and substance satisfactory to Cowen and its counsel, dated the date that the opinion is required to be delivered, substantially similar to the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 7(n)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;7(n)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, respectively, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in lieu of such opinions for subsequent Bring-Down Dates, counsel may furnish Cowen with a letter (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Reliance Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the effect that Cowen may rely on a prior opinion delivered under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to the same extent as if it were dated the date of such letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented at such Bring-Down Date).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  On or prior to the First Delivery Date and within three (3) Trading Days of each Bring-Down Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> for which no waiver is </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applicable, the Company shall cause its independent accountants to furnish Cowen letters (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Comfort Letters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), dated the date the Comfort Letter is delivered, in form and substance satisfactory to Cowen, (i) confirming that they are an independent registered public accounting firm within the meaning of the Securities Act and the PCAOB, (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to Cowen in connection with registered public offerings (the first such letter, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Initial Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Market Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares or (ii) sell, bid for, or purchase the Common Stock to be issued and sold pursuant to this Agreement, or pay anyone any compensation for soliciting purchases of the Placement Shares other than Cowen&#59; provided, however, that the Company may bid for and purchase shares of its common stock in accordance with Rule 10b-18 under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company and its subsidiaries shall maintain, or cause to be maintained, insurance in such amounts and covering such risks as is reasonable and customary for the business for which it is engaged.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.03pt;text-decoration:underline">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company and each of its subsidiaries shall maintain, or cause to be maintained, all material environmental permits, licenses and other authorizations required by federal, state and local law in order to conduct their businesses as described in the Prospectus, and the Company and each of its subsidiaries shall conduct their businesses, or cause their businesses to be conducted, in substantial compliance with such permits, licenses and authorizations and with applicable environmental laws, except where the failure to maintain or be in compliance with such permits, licenses and authorizations could not reasonably be expected to result in a Material Adverse Change.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.36pt;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor its subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act, assuming no change in the Commission&#8217;s current interpretation as to entities that are not considered an investment company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.69pt;text-decoration:underline">Securities Act and Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will use its best efforts to comply with all requirements imposed upon it by the Securities Act and the Exchange Act as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Placement Shares as contemplated by the provisions hereof and the Prospectus.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">No Offer to Sell</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Other than a Permitted Free Writing Prospectus, neither Cowen nor the Company (including its agents and representatives, other than Cowen in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Common Stock hereunder.</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company and its subsidiaries will use their best efforts to comply with all effective applicable provisions of the Sarbanes-Oxley Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.36pt;text-decoration:underline">Affirmation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Placement Notice delivered by the Company to Cowen shall be deemed to be (i) an affirmation that the representations, warranties and agreements of the Company herein contained and contained in any certificate delivered to Cowen pursuant hereto are true and correct at the time of delivery of such Placement Notice, and (ii) an undertaking that such representations, warranties and agreements will be true and correct on any applicable Time of Sale and Settlement Date, as though made at and as of each such time  (it being understood that such representations, warranties and agreements shall relate to the Registration Statement and the Prospectus as amended and supplemented to the time of such Placement Notice acceptance).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Renewal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If immediately prior to the third anniversary (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Renewal Deadline</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) of the initial effective date of the Registration Statement, the aggregate gross sales price of Placement Shares sold by the Company is less than the Maximum Amount and this Agreement has not expired or been terminated, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new shelf registration statement relating to the Placement Shares, in a form satisfactory to Cowen, and, if not automatically effective, will use its best efforts to cause such registration statement to be declared effective within 60 days after the Renewal Deadline. The Company will take all other action necessary or appropriate to permit the issuance and sale of the Placement Shares to continue as contemplated in the expired registration statement relating to the Placement Shares. References herein to the Registration Statement shall include such new shelf registration statement.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Conditions to Cowen&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The obligations of Cowen hereunder with respect to a Placement Notice will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its obligations hereunder and thereunder, to the completion by Cowen of a due diligence review satisfactory to Cowen in its reasonable judgment, and to the continuing satisfaction (or waiver by Cowen in its sole discretion) of the following additional conditions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Registration Statement Effective</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Registration Statement shall be effective and shall be available for (i) all sales of Placement Shares issued pursuant to all prior Placement Notices and (ii) the sale of all Placement Shares contemplated to be issued pursuant to any Placement Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">No Material Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  None of the following events shall have occurred and be continuing&#58;  (i) receipt by the Company or any of its subsidiaries of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus&#59; (ii)&#160;the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose&#59; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose&#59; or </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related Prospectus or such documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">No Misstatement or Material Omission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cowen shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in Cowen&#8217;s reasonable opinion is material, or omits to state a fact that in Cowen&#8217;s opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Material Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as contemplated in the Prospectus, or disclosed in the Company&#8217;s reports filed with the Commission, there shall not have been any material adverse change, on a consolidated basis, in the authorized capital stock of the Company or any Material Adverse Change or any development that could reasonably be expected to result in a Material Adverse Change, or any downgrading in or withdrawal of the rating assigned to any of the Company&#8217;s securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it has under surveillance or review its rating of any of the Company&#8217;s securities (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of Cowen (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Company Counsel Legal Opinion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cowen shall have received the opinions of Company Counsel required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> on or before the date on which such delivery of such opinion is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.03pt;text-decoration:underline">Cowen Counsel Legal Opinion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cowen shall have received from Duane Morris LLP, counsel for Cowen, such opinion or opinions, on or before the date on which the delivery of the Company Counsel legal opinion is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, with respect to such matters as Cowen may reasonably require, and the Company shall have furnished to such counsel such documents as they request for enabling them to pass upon such matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Comfort Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cowen shall have received the Comfort Letter required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> on or before the date on which such delivery of such Comfort Letter is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Representation Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Cowen shall have received the certificate required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> on or before the date on which delivery of such certificate is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.69pt;text-decoration:underline">Secretary&#8217;s Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  On or prior to the First Delivery Date, Cowen shall have received a certificate, signed on behalf of the Company by its corporate secretary, in form and substance satisfactory to Cowen and its counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.69pt;text-decoration:underline">No Suspension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Trading in the Common Stock shall not have been suspended on Nasdaq.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Other Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  On each date on which the Company is required to deliver a certificate pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company shall have furnished to Cowen such appropriate further information, certificates and documents as Cowen may have reasonably requested. All such opinions, certificates, letters and other documents shall have been in compliance with the provisions hereof. The Company will furnish Cowen with such conformed copies of such opinions, certificates, letters and other documents as Cowen shall have reasonably requested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.69pt;text-decoration:underline">Securities Act Filings Made</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15.69pt;text-decoration:underline">Approval for Listing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Placement Shares shall either have been (i) approved for listing on Nasdaq, subject only to notice of issuance, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq at, or prior to, the issuance of any Placement Notice.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">No Termination Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  There shall not have occurred any event that would permit Cowen to terminate this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21pt;text-decoration:underline">Indemnification and Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Company Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company agrees to indemnify and hold harmless Cowen, the directors, officers, partners, employees and agents of Cowen and each person, if any, who (i) controls Cowen within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, or (ii) is controlled by or is under common control with Cowen from and against any and all losses, claims, liabilities, expenses and damages (including, but not limited to, any and all reasonable investigative, legal and other expenses  incurred in connection with, and any and all amounts paid in settlement (in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of, any action, suit or proceeding between any of the indemnified parties and any indemnifying parties or between any indemnified party and any third party, or otherwise, or any claim asserted), as and when incurred, to which Cowen, or any such person, may become subject under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based, directly or indirectly, on (x) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus or any amendment or supplement to the Registration Statement or the Prospectus or in any free writing prospectus or in any application or other document executed by or on behalf of the Company or based on written information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify the Common Stock under the securities laws thereof or filed with the Commission, (y) the omission </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or alleged omission to state in any such document a material fact required to be stated in it or necessary to make the statements in it not misleading or (z) any breach by any of the indemnifying parties of any of their respective representations, warranties and agreements contained in this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that this indemnity agreement shall not apply to the  extent that such loss, claim, liability, expense or damage arises from the sale of the Placement Shares pursuant to this Agreement and is caused directly or indirectly by an untrue statement or omission made in reliance upon and in conformity with solely Agent&#8217;s Information.  &#8220;Agent&#8217;s Information&#8221; means, solely, the following information in the Prospectus&#58; the eighth paragraph under the caption &#8220;Plan of Distribution&#8221; in the Prospectus.  This indemnity agreement will be in addition to any liability that the Company might otherwise have.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Cowen Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Cowen agrees to indemnify and hold harmless the Company and its directors and each officer of the Company that signed the Registration Statement, and each person, if any, who (i)&#160;controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Agent&#8217;s Information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt;text-decoration:underline">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any party that proposes to assert the right to be indemnified under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (ii) any liability that it may have to any indemnified party under the foregoing provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable and documented fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly as they are incurred after the indemnifying party receives a written notice relating to fees, disbursements and other charges. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent.  No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising or that may arise out of such claim, action or proceeding. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt;text-decoration:underline">Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or Cowen, the Company and Cowen will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than Cowen, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and Cowen may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and Cowen on the other. The relative benefits received by the Company on the one hand and Cowen on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by Cowen from the sale of Placement Shares on behalf of the Company.  If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and Cowen, on the other, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or Cowen, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and Cowen agree that it would not be just and equitable if contributions pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> were to be determined by pro rata allocation or by any other method of allocation that does</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be deemed to include, for the purpose of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof.  Notwithstanding the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Cowen shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, any person who controls a party to this Agreement within the meaning of the Securities Act, and any officers, directors, partners, employees or agents of Cowen, will have the same rights to contribution as that party, and each officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Representations and Agreements to Survive Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The indemnity and contribution agreements contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of Cowen, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii) any termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt">Cowen shall have the right by giving notice as hereinafter specified at any time to terminate this Agreement if (i) any Material Adverse Change, or any development that could reasonably be expected to result in a Material Adverse Change has occurred that, in the reasonable judgment of Cowen, may materially impair the ability of Cowen to sell the Placement Shares hereunder, (ii) the Company shall have failed, refused or been unable to perform any agreement on its part to be performed hereunder, (iii)&#160;any other condition of Cowen&#8217;s obligations hereunder is not fulfilled, or (iv) any suspension or limitation of trading in the Placement Shares or in securities generally on Nasdaq shall have occurred.  Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Expenses), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Indemnification and Contribution), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Representations and Agreements to Survive Delivery), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Applicable Law&#59; Consent to Jurisdiction) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Waiver of Jury Trial) hereof shall remain in full force and effect notwithstanding such termination. If </font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cowen elects to terminate this Agreement as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Cowen shall provide the required notice as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (Notices).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt">The Company shall have the right, by giving ten (10) days&#8217; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement.  Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt">Cowen shall have the right, by giving ten (10) days&#8217; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement.  Any such termination shall be without liability of any party to any other party except that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt">Unless earlier terminated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through Cowen on the terms and subject to the conditions set forth herein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof shall remain in full force and effect notwithstanding such termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt">This Agreement shall remain in full force and effect unless terminated pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(c), or (d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> above or otherwise by mutual agreement of the parties&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that any such termination by mutual agreement shall in all cases be deemed to provide that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.03pt">Any termination of this Agreement shall be effective on the date specified in such notice of termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such termination shall not be effective until the close of business on the date of receipt of such notice by Cowen or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.97pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.97pt;font-weight:400;line-height:120%">. All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified in this Agreement, and if sent to Cowen, shall be delivered to Cowen at Cowen and Company, LLC, 599 Lexington Avenue, New York, NY 10022, fax no. 646-562- 1130, Attention&#58;  General Counsel, with a copy to Duane Morris LLP, 1540 Broadway, New York, NY 10036, Attention&#58; James T. Seery&#59; or if sent to the Company, shall be delivered to Exagen Inc., 1261 Liberty Way, Vista, CA 92081, attention&#58; Fortunato Ron Rocca&#59; Kamal Adawi, with a copy to Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., attention&#58; Scott Stanton&#59; Melanie Ruthrauff Levy. Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before 4&#58;30 p.m., New York City time,on a Business Day (as defined below), or, if such day is not a</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Business Day on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier, (iii) on the Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid) and (iv) when delivered by electronic communication (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Electronic Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), at the time the party sending such Electronic Notice receives verification of receipt by the receiving party, other than via auto-reply. For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any day on which the Nasdaq and commercial banks in the City of New York are open for business.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall inure to the benefit of and be binding upon the Company and Cowen and their respective successors and the affiliates, controlling persons, officers and directors referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Cowen may assign its rights and obligations hereunder to an affiliate of Cowen without obtaining the Company&#8217;s consent.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Adjustments for Share Splits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share split, share dividend or similar event effected with respect to the Common Stock.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Entire Agreement&#59; Amendment&#59; Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and Cowen.  In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Applicable Law&#59; Consent to Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the principles of conflicts of laws. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.  Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt requested) to such party at the address in effect for</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.6pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company and Cowen each hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this Agreement or any transaction contemplated hereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Absence of Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt">Cowen has been retained solely to act as an arm&#8217;s length contractual counterparty to the Company in connection with the sale of the Placement Shares contemplated hereby and that no fiduciary, advisory or agency relationship between the Company and Cowen has been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether Cowen has advised or is advising the Company on other matters&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt">the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.7pt">the Company has been advised that Cowen and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that Cowen has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.02pt">the Company waives, to the fullest extent permitted by law, any claims it may have against Cowen, for breach of fiduciary duty or alleged breach of fiduciary duty and agrees that Cowen shall have no liability (whether direct or indirect) to the Company in respect of such a fiduciary claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including stockholders, partners, employees or creditors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:15pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile or electronic transmission.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Remainder of Page Intentionally Blank&#93;</font></div><div style="height:57.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 30</font></div></div></div><div id="i26424b9a90484f998a65145809733d5a_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If the foregoing correctly sets forth the understanding between the Company and Cowen, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and Cowen.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COWEN AND COMPANY, LLC</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Michael Murphy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; Michael Murphy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; Managing Director</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACCEPTED as of the date</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">first-above written&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXAGEN INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Kamal Adawi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Kamal Adawi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Financial Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i26424b9a90484f998a65145809733d5a_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">FORM OF PLACEMENT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">From&#58;&#160;&#160;&#160;&#160;Exagen Inc.</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cc&#58;&#160;&#160;&#160;&#160;&#91;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></div><div style="padding-left:72pt;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To&#58; &#160;&#160;&#160;&#160;&#91; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#93;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject&#58; &#160;&#160;&#160;&#160;Cowen At the Market Offering&#8212;Placement Notice</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the terms and subject to the conditions contained in the Sales Agreement between Exagen Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and Cowen and Company, LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cowen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) dated September 15, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), I hereby request on behalf of the Company that Cowen sell up to &#91;  &#93; shares of the Company&#8217;s common stock, par value &#91;_&#93; per share, at a minimum market price of $0.001 per share.  Sales should begin on the date of this Notice and shall continue until &#91;DATE&#93; &#91;all shares are sold&#93;.</font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 2</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Notice Parties</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Company</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Fortunato Ron Rocca&#160;&#160;&#160;&#160;Chief Executive Officer</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kamal Adawi&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Chief Financial Officer</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Cowen</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Michael J. Murphy&#160;&#160;&#160;&#160;Managing Director</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">William Follis&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Managing Director</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SCHEDULE 3</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Compensation</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cowen shall be paid compensation equal to 3.0% of the gross proceeds from the sales of Placement Shares pursuant to the terms of this Agreement.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> 3</font></div></div></div><div id="i26424b9a90484f998a65145809733d5a_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit 7(m) </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">OFFICER CERTIFICATE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The undersigned, the duly qualified and elected __, of Exagen Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), a Delaware corporation, does hereby certify in such capacity and on behalf of the Company, pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Sales Agreement dated September 15, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Sales Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) between the Company and Cowen and Company, LLC, that to the best of the knowledge of the undersigned.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;The representations and warranties of the Company in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Sales Agreement (A) to the extent such representations and warranties are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Change, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B) to the extent such representations and warranties are not subject to any qualifications or exceptions, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those representations and warranties that speak solely as of a specific date and which were true and correct in all material respects as of such date&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;The Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied pursuant to the Sales Agreement at or prior to the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.391%"><tr><td style="width:1.0%"></td><td style="width:25.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;__________________________</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Title&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58;_____________</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex51-exagenxatmxformof51op.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iffa09d05940c4b7aa9ce3d13bac053cb_1"></div><div style="min-height:225.36pt;width:100%"><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 5.1</font></td></tr><tr style="height:65pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="image_1.jpg" src="image_1.jpg" style="height:106px;margin-bottom:5pt;vertical-align:text-bottom;width:84px"></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:right;text-indent:-1.25pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3580 Carmel Mountain Road, Suite 300</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">San Diego, CA  92130</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">858-314-1500</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">www.mintz.com</font></div></td></tr></table></div></div><div style="padding-left:108pt;padding-right:108pt;text-align:center;text-indent:-216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">September 15, 2022</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exagen Inc.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1261 Liberty Way</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vista, California 92081</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58; </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have acted as counsel to Exagen Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), in connection with the preparation and filing with the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) of a Prospectus Supplement, dated September 15, 2022, to a Prospectus, dated November 19, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Prospectus and Prospectus Supplement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), filed pursuant to a Registration Statement on Form S-3, Registration No. 333-250015 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Registration Statement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), pursuant to which the Company is registering under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the sale of up to $50.0 million of shares (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) of common stock, $0.001 par value per share (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), of the Company.  The Shares are being sold pursuant to a Sales Agreement Agreement, dated as of September 15, 2022, by and between the Company and Cowen and Company, LLC (the&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sales Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), pursuant to which the Company may issue and sell the Shares pursuant to the Registration Statement and the Prospectus and Prospectus Supplement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with this opinion, we have examined the Company&#8217;s Certificate of Incorporation, as amended to date, and Bylaws, both as currently in effect, such other records of the corporate proceedings of the Company and certificates of the Company&#8217;s officers as we have deemed relevant, as well as the Registration Statement and the exhibits thereto and the Prospectus and the Prospectus Supplement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, photostatic or facsimile copies and the authenticity of the originals of such copies. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Based upon the foregoing, and subject to the limitations set forth below, we are of the opinion that the Shares, when issued by the Company out of the Company&#8217;s duly authorized Common Stock and issued and delivered by the Company against payment therefor as contemplated by the Sales Agreement, on terms approved by the Board of Directors of the Company, or a duly authorized committee thereof, will be duly and validly issued, fully paid and nonassessable.</font></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BOSTON&#160;&#160;&#160;&#160;&#160;&#160;&#160;LONDON&#160;&#160;&#160;&#160;&#160;&#160;&#160;LOS ANGELES&#160;&#160;&#160;&#160;&#160;&#160;&#160;NEW YORK&#160;&#160;&#160;&#160;&#160;&#160;&#160;SAN DIEGO&#160;&#160;&#160;&#160;&#160;&#160;&#160;SAN FRANCISCO&#160;&#160;&#160;&#160;&#160;&#160;WASHINGTON</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.</font></div></td></tr></table></div><div><font><br></font></div></div></div><div id="iffa09d05940c4b7aa9ce3d13bac053cb_51"></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MINTZ</font></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 15, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:0 1pt"><div><img alt="image_0.jpg" src="image_0.jpg" style="height:54px;margin-bottom:5pt;vertical-align:text-bottom;width:42px"></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page 2</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Our opinion is limited to the General Corporation Law of the State of Delaware, and we express no opinion with respect to the laws of any other jurisdiction. No opinion is expressed herein with respect to the qualification of the Shares under the securities or blue sky laws of any state or any foreign jurisdiction.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We have relied as to certain matters on information obtained from public officials, officers of the Company, and other sources believed by us to be responsible.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We hereby consent to the filing of this opinion as an exhibit to a Current Report on Form 8-K in accordance with the requirements of Item&#160;601(b)(5) of Regulation&#160;S-K under the Securities Act and to the use of this firm&#8217;s name therein and in the Prospectus and Prospectus Supplement under the caption &#8220;Legal Matters.&#8221; In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&#160;7 of the Securities Act or the rules and regulations of the Commission. </font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Very truly yours,</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#47;s&#47; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo,&#160;P.C.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo,&#160;P.C.</font></td></tr></table></div><div style="height:81.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>exdx-20220915.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a944869c-9527-48e0-9937-aeba75b47e0d,g:ad3d43e1-ed49-4e9b-aa6c-71416205d4a9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exdx="http://www.exagen.com/20220915" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exagen.com/20220915">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exdx-20220915_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exdx-20220915_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.exagen.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>exdx-20220915_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a944869c-9527-48e0-9937-aeba75b47e0d,g:ad3d43e1-ed49-4e9b-aa6c-71416205d4a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_18ac26d3-6a71-4049-a885-2b93dd9635d9_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7e5b733f-4890-4c7e-8a32-4e0b672c1b44_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_60c9ba98-ddb3-489f-96ef-43947cb3ed7b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_8ef8ee24-157b-4a79-8213-da54751790f2_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_afcb107a-c358-4e91-9388-a9272beb2d12_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e665bd27-a5a3-4af7-bc53-e7466aad2adc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_85280060-59a3-4ec1-a937-bb7aea5cfa3c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_cbe8a2e5-47d1-4fa4-8831-89575574d381_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_a789219c-e33f-4e53-86b9-717c537dc1c6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ad7c2fd8-ed3a-480f-9a5d-08d88b57571a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_61b76222-5146-492d-af45-0e4d29a82557_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8929e9c2-3a0b-4877-8676-32f781e48303_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_f70fa57e-58ec-4c02-ab2f-62dc4cd5f8d6_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_356e7783-3198-4b59-afaf-691ba63383db_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2546b989-6e07-463c-9c42-fe927b679a89_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f603772b-f35e-4990-a59c-0d7ba9f6f0dc_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_655a96b4-adca-415c-b0b7-b7714491eb66_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_653d971f-00d4-4342-a054-abaa55f7a1d6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f42a5deb-9fd8-4139-bdf3-5b5d21cad0f4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0898a4af-f49d-4eec-b347-40e3a95a5c7f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1cb97464-6f6d-452c-a4ea-23ec67ec89de_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_900acd29-3e0f-463d-9ff4-1bdcce57f996_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6af85d2d-9171-43e6-96dc-51bc8ea3e515_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>exdx-20220915_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a944869c-9527-48e0-9937-aeba75b47e0d,g:ad3d43e1-ed49-4e9b-aa6c-71416205d4a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.exagen.com/role/Cover" xlink:type="simple" xlink:href="exdx-20220915.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.exagen.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9f1bca8a-9bd6-4c3b-818b-7377639646a6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_DocumentType_9f1bca8a-9bd6-4c3b-818b-7377639646a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5e99b616-8ffe-41a2-8748-efa50c38b19a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_DocumentPeriodEndDate_5e99b616-8ffe-41a2-8748-efa50c38b19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_49595f91-3d7c-470b-a164-9a5f40ab6b38" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityRegistrantName_49595f91-3d7c-470b-a164-9a5f40ab6b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_03339c85-fed8-4188-b954-8a34dacff00e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityIncorporationStateCountryCode_03339c85-fed8-4188-b954-8a34dacff00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3cfc9017-43f7-45d9-a46b-b034b4eb3232" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityFileNumber_3cfc9017-43f7-45d9-a46b-b034b4eb3232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c9a6da97-d9c7-416d-b7c7-a8c768078f1c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityTaxIdentificationNumber_c9a6da97-d9c7-416d-b7c7-a8c768078f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_48814943-313c-43ca-ad81-537ff72ae917" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityAddressAddressLine1_48814943-313c-43ca-ad81-537ff72ae917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e51bf3d0-b82e-44f3-8758-27ae2652e3af" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityAddressCityOrTown_e51bf3d0-b82e-44f3-8758-27ae2652e3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6dd19a49-2157-4d55-89ae-b1f44ed7165c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityAddressStateOrProvince_6dd19a49-2157-4d55-89ae-b1f44ed7165c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d52d82f4-1a60-40cb-935c-57e860e300a2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityAddressPostalZipCode_d52d82f4-1a60-40cb-935c-57e860e300a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b3bd7743-0800-4da7-acd7-a537632595d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_CityAreaCode_b3bd7743-0800-4da7-acd7-a537632595d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_700eb5d8-72d1-4809-abf5-ce8479d59bc2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_LocalPhoneNumber_700eb5d8-72d1-4809-abf5-ce8479d59bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_14a8ec8b-18e0-4a74-928b-5b695f87b70e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_WrittenCommunications_14a8ec8b-18e0-4a74-928b-5b695f87b70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7580168c-364b-405f-8fc3-aa69a8c40e61" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_SolicitingMaterial_7580168c-364b-405f-8fc3-aa69a8c40e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_157d7afe-ff3d-4483-8afe-7b721aa0145e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_PreCommencementTenderOffer_157d7afe-ff3d-4483-8afe-7b721aa0145e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_c4a062ae-97b7-44ed-b566-9fd1f96b0045" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_c4a062ae-97b7-44ed-b566-9fd1f96b0045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0480c964-79b9-48e4-bfb7-a3599f6a441d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_Security12bTitle_0480c964-79b9-48e4-bfb7-a3599f6a441d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_155cd15a-f071-4112-87bf-78bdd2f42085" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_TradingSymbol_155cd15a-f071-4112-87bf-78bdd2f42085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_14958ad8-46f3-4614-a9b4-ba3f90d5b78a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_SecurityExchangeName_14958ad8-46f3-4614-a9b4-ba3f90d5b78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e05984f5-4881-4a4c-97e2-1370ed6acd08" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityEmergingGrowthCompany_e05984f5-4881-4a4c-97e2-1370ed6acd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_2125960a-fcb8-4640-9666-41fd77a86687" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityExTransitionPeriod_2125960a-fcb8-4640-9666-41fd77a86687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e0514ddc-132c-4380-aff7-0102f843cd00" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_EntityCentralIndexKey_e0514ddc-132c-4380-aff7-0102f843cd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_aa8bd9ea-9d0c-459c-815d-02e29a23550a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56accda1-1ec8-4c78-8c84-fb7bd288b830" xlink:to="loc_dei_AmendmentFlag_aa8bd9ea-9d0c-459c-815d-02e29a23550a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "T (X# 2(  A$! Q$!_\0
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M1\2?]A^\_P#1[U@5O_%;_DJ/B3_L/WG_ */>L"@ HHHH *Z;X+?%[QW^S_\
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M[Z_\&/>E:9KVE?M6:'K>G07EG>6_@R"\M+J%9(YXG77U9'5@0RL"001@@X-
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M^&_V$_VQ?#7[(_A9X9(? _P?\-V5Y=6V[R[R_:W::]NE#<J)KN6XFV]C+@
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MV\7?%+_BM?$Y=?WD:W<:?8;<Y563R[);<M$V=DTD^.IS_-;_ ,$8_P!A:?\
MX**?\%'_ (:_LWZGX=DU#PO)K*ZOX^4>>L2:#9D3W:22P8> 3*HM4D#+B6ZB
M 8$@U_:M!#%;0);PQ*B1J%5$7 4 = /2@#^3O_@[C_Y3.>)_^Q)T#_TDK\R:
M_33_ (.X/^4SWBK_ +$O0/\ TC%?F70 5U'PE_Y&.;_KQ;_T-*Y>NH^$O_(Q
MS?\ 7BW_ *&E %;XK?\ )4?$G_8?O/\ T>]8%;_Q6_Y*CXD_[#]Y_P"CWK H
M *_?W_@QD^]^U#_W)/\ [GZ_ *OW]_X,9/O?M0_]R3_[GZ /W_(SU%?R=?\
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M\*M?TJ.Z\*>&;O\ X2WQQ'/:I/#)IFGNDGV>6-R T=Q<-;6C=<+=%L-M(/\
M9:H(7!K\9O\ @S0_8:B^$G[&?BK]N'Q9H\:ZU\6-<;3_  Y/)&C-'H>G2/$6
M1L;X_.O3<ATSAA9P-SQC]FJ "BBB@#^3#_@[6;/_  6E\9#'3PCX?_\ 2!*_
M-*OTL_X.U3_QNF\:?]BCX?\ _2".OS3H *ZCX2_\C'-_UXM_Z&E<O74?"7_D
M8YO^O%O_ $-* /Z!/$__  9(?"_Q/XEU'Q)+_P %"=?A;4+Z:Y:%?AW P0NY
M;&?MHZ9JC_Q Z?"S_I(EX@_\-Q!_\G5^[U% 'X0_\0.GPL_Z2)>(/_#<0?\
MR=7W;_P1/_X(<^&?^",K_$P^&?VBM0\?+\2/[%\[[=X;33_L/]G_ &[&W9/+
MYF_[:>NW;Y??=Q]XT4 %%%% !7QK_P %FO\ @C=\*O\ @L7\(?"?P]\:_$6Y
M\%ZUX,\02:AHOBJQTE;V:.WFA,=S9^4TL:^7*RV\A;.0UJF."P/V510!^$/_
M ! Z?"S_ *2)>(/_  W$'_R=0?\ @QU^%G;_ (*(^(/_  W,'_R=7[O44 <;
M^SM\#? _[,GP(\'_ +/'PTL3;^'_  3X:LM$TA&QO:"VA6)7<@#=(VW<S=69
MF)Y)KLJ** "@Y[444 ?E7_P50_X-?? W_!4#]L?6OVO-?_;"U;P?<:QI=A9-
MH=GX-BO$B%K;K"&$K749.[;G&T8SCFOG7_B!T^%G_21+Q!_X;B#_ .3J_=ZB
M@#\(?^('3X6?])$O$'_AN(/_ ).K2\+?\&3/PQ\+:B^H0_\ !0;7IM\)CVM\
M.X%QD@Y_X_?:OW,HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ^>_P!@_P#X*F?L-?\ !2RS\17?[&WQI7Q2WA.:W37[6;1;S3Y[7SPY
MB?R[N*-F1O+D 901E&!((KZ$K^,O_@E=\;/VL_\ @FYXDTO_ (*U_!3PO+K?
M@/PKXT7P;\2M+M[MHTN;2\@2;[)<@<JDRHS0S%72*YM82X),:2?V _L\_M ?
M";]J?X(^&?VAO@9XOM]>\)^+M(BU'1=3M6XDC<<HXZQRHP:.2-L/'(CHP#*0
M #LF;:,U\Z?LP_\ !5_]@W]LK]HWQ?\ LI?LU_'&/Q5XT\"V]U/XCM;'1KQ;
M6*.WNH[65XKMX5M[A1-(BAHG<,#N4LO-?*7_  <F_P#!5SQ5^QW\"]+_ &*/
MV4;B_P!0^/?QP"Z3X;L_#LS-J6C:?<2?9VNXHX@9?M,\A-K:[=C&0RRH^ZVV
M-^?W_!H]\$_&?[-G_!8KX^?L^?$;[+_PD'@GX;:KH>N"QF\R$7=MKNG0S!'P
M-ZAT8!L#(YH _HZKP#]B7_@I[^Q?_P %$-<\;^'/V2OBE<>)+OX=75K;^+HY
MO#][8BSDN6N5A -U#&)<FTN.4W ;!G&X9]_K\)O^#,S_ )+'^V=_V,WA?_TH
M\14 ?N?K6KV/A_2+K7=4E,=K9V[SW$BJ6VQHI9C@9)P >!S7B'["7_!3+]BK
M_@I3X6UWQ?\ L;_&B#Q5;^&=0CL]>MY--N;&ZLGD3?$[V]U''*(W <)+MV.T
M4JJQ,;@>L_%?_DEOB7_L7[S_ -$/7\C?_!+6]_;3_P""='P;T[_@N3^S9;GQ
M!X)\+_$ZZ\ _%CPFC/$DFFM;:9<)]H=2V(9WO1&DNPBWN8+=B)/,"4 ?V"5Y
M;^V)^V;^SQ^P5\$+S]HO]J+QM+X?\(V-];V=UJ4.DW-ZR33OLC7RK:.20Y;C
M(7 [XJ7]CO\ :Y^"/[='[.?AG]J#]GKQ*=2\,^*+$36_G($N+.8';+:W"!F\
MN>*0-&ZY(W+E692K'X:_X.WO^4,'BS_L=- _]+!0!^AWPA^*_@?X[?"3PO\
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M_P /_">F>!/!'AZRTC1=%T^&QTG2=-MEAMK*UB01Q011H L<:(JJJJ
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M+?[0WAU;S1M:A\RQU"%1]KT:_16\C4+5R/W<\18D?PNK/&X>.1T;^93]MO\
M:%_;+_8%_8F^)7_! 3]N[P_<7[>']>TK7/A#XNAW-!)IBWWF-'#(X!N+"5?,
MDA?A[>6.>W<9 CMP#^E#_@DY_P HL?V:?^R >#?_ $R6=?0%?/\ _P $G/\
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IOO\ Z/C^,/\ X<S5?_DBC_AX1^WW_P!'Q_&'_P .9JO_ ,D444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" #R +X# 2(  A$! Q$!_\0
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M5RE=7\=_^2X>,O\ L:]1_P#2F2N4H **** "BBB@ HHHH ^B/^"4O[<VM_\
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MJ$)(+1C;^%M !1110 4444 %%%% !76_!O\ Y&>X_P"O!O\ T-*Y*NM^#?\
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M6.)%' %>=T44 %%%% !16U\.?A]XR^+?Q"T'X4_#K09M5\0>)M:M=)T'2[8
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M7_I\O*_M\K^(/_@K%_RE-_:6_P"S@/&7_I\O* /G^BBB@ KK?@W_ ,C/<?\
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MZL)[&=,D$F-HY]Y4$?O(('ZQK7\A/_!?#]ON/_@HK_P4W\>_&+PYJ4=UX/\
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M7AOPGH5GHWA[2XYI)%L[&UA2""$/(S.P2-%7<S%CC)).30!O4444 %?Q!_\
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MD_E76U8/#ML(LR37%SYB^>B ?NW2#]X9YDB /F3_ (*R?MJ_'K_@Y!_X*/\
MA;_@F]^P'!-=_"_PMKT@T_4WF866HSQYCO/$UYMXCLX(GD2W!W2,CL4!EO%M
MU_H"_8$_87^!G_!.;]EOPW^RM\ -#%OI.AV^_4-3FC'VK6M0< W&H7+#[\TK
M#Z(BQQ(%CC1%^8?^#?/_ ((Q^&_^"4G[,"Z]\1]&@G^-7CZS@N?B#J7GI-_9
M48&^+1[=D)01PEB970GSIMS;WCC@$?Z"4 ?S2_\ !DO_ ,GY_%K_ +)'_P"Y
M2SK^BSX^? GX5?M._!GQ+^S_ /'#PA;:]X3\7:1-INN:5= [9H9!C*L,-'(I
MPZ2*0\;HKH5901_.G_P9+_\ )^?Q:_[)'_[E+.OZ6J /YR_^"=W_  :F_%+P
MQ_P5F\2>&?VN]!DU3X%_"F_BU?0]=N-/!M?B"LC[]/LL,0%55!:]0"14: V_
M*W"3C^C3IVHHH _G+U;_ )7=%_[':'_U#5K^C2OYR]6_Y7=%_P"QVA_]0U:_
MHTH ^ _^#HC_ )05_'3_ '?#?_J3:57B?_!F9_RB9U__ ++3K'_IOTRO;/\
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MDM+)S)*%DS^]N7N$_=RT_P"#M;_@BO86L=C8_$KQE###&J0PQ?#Z[544# 4
M#  '  Z4 ?IQ17YE_P#$7#_P1A_Z*EXU_P#"!N_\*/\ B+A_X(P_]%2\:_\
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J $,GA[_TZ0444 ?R6;%_NC\J-B_W1^5%% !L7^Z/RHV+_='Y444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139768009129472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 15,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXAGEN INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-0434866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1261 Liberty Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Vista<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">560-1501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XGN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001274737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>exdx-20220915_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="exdx-20220915.xsd" xlink:type="simple"/>
    <context id="ib7fec472c1a446339220282dc241a296_D20210805-20210805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001274737</identifier>
        </entity>
        <period>
            <startDate>2021-08-05</startDate>
            <endDate>2021-08-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M180L2ZyYWc6MGIyYjlkYmRlYTVmNDFhYTlkODZlZTVjNTRhMGM1NGIvdGFibGU6MmY2MmQxMzFkMDNiNDYwNzlmYzIwYjNkMmVkMTBmZjAvdGFibGVyYW5nZToyZjYyZDEzMWQwM2I0NjA3OWZjMjBiM2QyZWQxMGZmMF8wLTEtMS0xLTQ2NTQ5_165e160c-4180-4e1e-8bf7-4d4613231a1d">0001274737</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M180L2ZyYWc6MGIyYjlkYmRlYTVmNDFhYTlkODZlZTVjNTRhMGM1NGIvdGFibGU6MmY2MmQxMzFkMDNiNDYwNzlmYzIwYjNkMmVkMTBmZjAvdGFibGVyYW5nZToyZjYyZDEzMWQwM2I0NjA3OWZjMjBiM2QyZWQxMGZmMF8xLTEtMS0xLTQ2NTQ5_c3022e7c-8ce3-46cf-9134-53adb531dfa0">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTEy_2a5a851f-96e2-4408-bf30-168cd6b8a0e2">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yMjk_0fbd25c2-1c3a-4a7f-9fc8-87402f801e1f">2022-09-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTEz_1680aa00-520b-46d7-aca3-e6a324a06c0c">EXAGEN INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6N2I3N2ExNWQ3MjA5NDVmMmI5YWFiZGNhZjM3MWMyOGIvdGFibGVyYW5nZTo3Yjc3YTE1ZDcyMDk0NWYyYjlhYWJkY2FmMzcxYzI4Yl8xLTAtMS0xLTQ2NTQ5_93a6e947-cc7c-41cf-937e-11e818eb4622">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6N2I3N2ExNWQ3MjA5NDVmMmI5YWFiZGNhZjM3MWMyOGIvdGFibGVyYW5nZTo3Yjc3YTE1ZDcyMDk0NWYyYjlhYWJkY2FmMzcxYzI4Yl8xLTItMS0xLTQ2NTQ5_076d1404-8148-4dd3-86ce-ecf5bee5c686">001-39049</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6N2I3N2ExNWQ3MjA5NDVmMmI5YWFiZGNhZjM3MWMyOGIvdGFibGVyYW5nZTo3Yjc3YTE1ZDcyMDk0NWYyYjlhYWJkY2FmMzcxYzI4Yl8xLTQtMS0xLTQ2NTQ5_2c273da1-4c60-4c11-bfdf-0fcaf00a85c3">20-0434866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE2_6ea5f31d-a496-48ed-ba8e-2814912a8352">1261 Liberty Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE3_9369833a-a86f-45ae-b3da-b9537a2878bd">Vista</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE4_dfb3ddfa-3acb-4661-a05e-f9ea7d989f65">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE0_d29cd655-0c7f-46c6-a207-f0e10163f257">92081</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE1_1d898c82-8404-4665-8cfe-4d1014a18739">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTE5_8b452a05-3349-4fa3-a20c-8b5737ce4ef6">560-1501</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8wLTAtMS0xLTQ2NTQ5_8f4f5901-5520-41f7-b6f1-937e7ca107e5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8xLTAtMS0xLTQ2NTQ5_ae7d6762-b7c1-496c-8a81-708cd934a096">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8yLTAtMS0xLTQ2NTQ5_a8c57ae6-584a-4f80-b690-7f54a0b59658">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6NmI3YTQ5MzQ3Y2FlNDFiZjk2YTJkZDVmYzRiMTViNDkvdGFibGVyYW5nZTo2YjdhNDkzNDdjYWU0MWJmOTZhMmRkNWZjNGIxNWI0OV8zLTAtMS0xLTQ2NTQ5_403c9bad-dc7a-442f-8200-a5035e57f0ec">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6YTFhNjQ4MGVjNWMxNDUyM2JmMDJjYWQxMjZjN2ZlMjMvdGFibGVyYW5nZTphMWE2NDgwZWM1YzE0NTIzYmYwMmNhZDEyNmM3ZmUyM18yLTAtMS0xLTQ2NTQ5_342b9b9d-0874-46b5-903e-c57594f5aed8">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6YTFhNjQ4MGVjNWMxNDUyM2JmMDJjYWQxMjZjN2ZlMjMvdGFibGVyYW5nZTphMWE2NDgwZWM1YzE0NTIzYmYwMmNhZDEyNmM3ZmUyM18yLTItMS0xLTQ2NTQ5_a6c3399e-543c-4681-bef2-05b4c37a9274">XGN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGFibGU6YTFhNjQ4MGVjNWMxNDUyM2JmMDJjYWQxMjZjN2ZlMjMvdGFibGVyYW5nZTphMWE2NDgwZWM1YzE0NTIzYmYwMmNhZDEyNmM3ZmUyM18yLTQtMS0xLTQ2NTQ5_0422782b-2a7c-4861-a775-b1b5bf4c1fee">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTIw_6dd47273-301a-4f84-b07b-189c80d396c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ib7fec472c1a446339220282dc241a296_D20210805-20210805"
      id="id3VybDovL2RvY3MudjEvZG9jOjM2MTk5YzI3M2JjNjQzN2ZhZDg5YWUyMzJmN2UzMjczL3NlYzozNjE5OWMyNzNiYzY0MzdmYWQ4OWFlMjMyZjdlMzI3M18xL2ZyYWc6YzMyODQ2ODViZDFmNDU3MWJkNjcyY2E2N2E1ODJkNmYvdGV4dHJlZ2lvbjpjMzI4NDY4NWJkMWY0NTcxYmQ2NzJjYTY3YTU4MmQ2Zl8yNTIx_5ae1867a-f1c8-4b4f-ad33-d505c3b40496">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#@0Y!LLQ6*;7P##(7\-%8C0DZN\RHH-"LUS!5N]]$G-/]!THST3HC7 &/_U
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !Q@"]5!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M '& +U5_3HQ5[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( '& +U697)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ <8 O5?G)
M2'E7!    Q$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( '& +U6?H!OPL0(  .(,   -
M  "  9H,  !X;"]S='EL97,N>&UL4$L! A0#%     @ <8 O59>*NQS
M$P(   L              ( !=@\  %]R96QS+RYR96QS4$L! A0#%     @
M<8 O5:K$(A8S 0  (@(   \              ( !7Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( '& +U4D'INBK0   /@!   :              "
M ;\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( '&
M+U5ED'F2&0$  ,\#   3              "  :02  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  .X3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="exdx-20220915.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exagen.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="exdx-20220915.htm">exdx-20220915.htm</File>
    <File>ex11-xgnxsalesagreement.htm</File>
    <File>ex51-exagenxatmxformof51op.htm</File>
    <File>exdx-20220915.xsd</File>
    <File>exdx-20220915_lab.xml</File>
    <File>exdx-20220915_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "exdx-20220915.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "exdx-20220915.htm"
     ]
    },
    "labelLink": {
     "local": [
      "exdx-20220915_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exdx-20220915_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "exdx-20220915.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "exdx",
   "nsuri": "http://www.exagen.com/20220915",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exdx-20220915.htm",
      "contextRef": "ib7fec472c1a446339220282dc241a296_D20210805-20210805",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.exagen.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exdx-20220915.htm",
      "contextRef": "ib7fec472c1a446339220282dc241a296_D20210805-20210805",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001274737-22-000064-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001274737-22-000064-xbrl.zip
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MR/-!N!MW(,]/T0B2$&^S8A,:*23#5E9;G68;,2R\]IFG<&P5'_TD1<\BMEJ
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M4JC+*]T]WKAKWKB:K);7'HP'3:TGZ7T&^$O#L"2INT5<.K)DB7$G%2K>2R+
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M !GZ[A0Q0_.)YU=*83BML,K7\2"H,&[I>U44[:':7IZ&.,J(3SBQ*PTJXVZ
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M!)E8V(2-5?(MH.RO0! 2^$/Z 02;2N0U1=SL1 EG*W'>V6DJSL//C<NVD&W
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M4#!O9US+W@%U0[_5]8]!'#EMG-7!,4>HH/#&S$U!LYLY3TI#W3@[0U0&#)<
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MT#++5A=Q;\R^V4YD.Y'M1+ZK2_ZX>5!I]?Y/_6@XA_^,TLGXE_\"4$L#!!0
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M!I4,!!VSM4:!>1> *>[Y\RVT#VY@KM>W?$/] T<M[\A_1.E\7C1TK]0B@UT
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M<_I@C*0J[Q)V[\FOF+X)Z/YAN&6&>_FB 2;)?)*W^,./,KEB8_3I.F($GV_
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MY116!(A"4@$Q%%$'/V@(D\W.,ES%),QWW;-D[ARFT'Z2-1;C)2P(=K-7/J5
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M<V3-55MOFS 4?L^O\'B>PR6D*:A)I;6J-"G;I*Y5^S89?"!6P6:V:=B_G^V
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MQ0+H[M0'L+P3<&2,N]-I$]S3SAS>\LE1R\_76;J]8#B&/D5",D#*"SJ@%Q#
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MJ**S71^\=<<OU*NS%]MWDO43\\]>_!]02P,$%     @ <8 O55%+S,K>!@
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M97-A9W)E96UE;G0N:'1M4$L! A0#%     @ <8 O52/C(;;!"P  BCT  !X
M             ( !$(\  &5X-3$M97AA9V5N>&%T;7AF;W)M;V8U,6]P+FAT
M;5!+ 0(4 Q0    ( '& +U5!J94-:A@   BA   1              "  0V;
M  !E>&1X+3(P,C(P.3$U+FAT;5!+ 0(4 Q0    ( '& +U6V-ZY<:0(  &@'
M   1              "  ::S  !E>&1X+3(P,C(P.3$U+GAS9%!+ 0(4 Q0
M   ( '& +U6)JV3RJ H  /]@   5              "  3ZV  !E>&1X+3(P
M,C(P.3$U7VQA8BYX;6Q02P$"% ,4    " !Q@"]544O,RMX&  #O,@  %0
M            @ $9P0  97AD>"TR,#(R,#DQ-5]P<F4N>&UL4$L%!@     &
-  8 F0$  "K(      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
